Skip to content
Open access · US-GOV via ClinicalTrials.gov Clinical trial

SENolytics to Improve Osteoporosis Therapy: a Randomised Controlled Clinical Trial The SENIOR Trial

Authors not listed

Odense University Hospital · 2023

Abstract

This randomised clinical trial aims to study osteoporosis as a disease of accelerated skeletal aging caused by the accumulation of senescent cells within the skeleton and investigate the effects and safety of senolytics(definition) and antioxidant therapy on bone.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
ClinicalTrials.gov
Canonical
link ↗
Fetched
2026-10-25 MST

Cite this

APA
Anonymous. (2023). SENolytics to Improve Osteoporosis Therapy: a Randomised Controlled Clinical Trial The SENIOR Trial. <em>Odense University Hospital</em>. https://clinicaltrials.gov/study/NCT06018467
Vancouver
Anonymous. SENolytics to Improve Osteoporosis Therapy: a Randomised Controlled Clinical Trial The SENIOR Trial. Odense University Hospital. 2023.
BibTeX
@misc{anon2023SENoly, title = {SENolytics to Improve Osteoporosis Therapy: a Randomised Controlled Clinical Trial The SENIOR Trial}, author = {Anonymous}, journal = {Odense University Hospital}, year = {2023}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings